NDC product
Childrens Dimetapp Multi-Symptom Cold and Flu
NDC 0031-2249 · GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Key facts
| Product NDC | 0031-2249 |
|---|---|
| Proprietary name | Childrens Dimetapp Multi-Symptom Cold and Flu |
| Labeler | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing start | Jan 1, 2020 |
| Marketing end | Sep 30, 2022 |
| Listing certified through | Sep 30, 2022 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: